Search by Drug Name or NDC
NDC 00002-1220-50 TAUVID 100 mCi/mL Details
TAUVID 100 mCi/mL
TAUVID is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is FLORTAUCIPIR F-18.
Product Information
| NDC | 00002-1220 |
|---|---|
| Product ID | 0002-1220_e82b7e9c-6569-415d-9498-084612225c12 |
| Associated GPIs | |
| GCN Sequence Number | 081124 |
| GCN Sequence Number Description | flortaucipir F-18 VIAL 370 MBQ INTRAVEN |
| HIC3 | H1Y |
| HIC3 Description | DIAGNOSTIC RADIOPHARM - AMYLOID/TAU IMAGING |
| GCN | 48161 |
| HICL Sequence Number | 046579 |
| HICL Sequence Number Description | FLORTAUCIPIR F-18 |
| Brand/Generic | Brand |
| Proprietary Name | TAUVID |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Flortaucipir F-18 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mCi/mL |
| Substance Name | FLORTAUCIPIR F-18 |
| Labeler Name | Eli Lilly and Company |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA212123 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00002-1220-50 (00002122050)
| NDC Package Code | 0002-1220-50 |
|---|---|
| Billing NDC | 00002122050 |
| Package | 1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-50) / 50 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2022-10-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |